CN Patent
CN113018273B — 一种固体制剂及其制备方法和用途
Assigned to Shanghai Xuantai Pharmaceutical Technology Co ltd · Expires 2024-08-09 · 2y expired
What this patent protects
本发明涉一种固体制剂及其制备方法和用途。特别地,该固体制剂为托法替布制剂。
USPTO Abstract
本发明涉一种固体制剂及其制备方法和用途。特别地,该固体制剂为托法替布制剂。
Drugs covered by this patent
- Xeljanz (Tofacitinib Citrate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.